GlassScriptPhysician profile
Jean-Benoit Houle
NPI 1639146103
$699.78
in general payments reported to CMS, 2019-2025
10 companies · $243 in 2025
The $243 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $17.59 · 2021: $120 · 2022: $26.89 · 2023: $111 · 2024: $65.76 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $420.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $315.51 | 2021-2025 | Evenity, Prolia, Prolia |
| Pacira Therapeutics, INC. | $146.32 | 2019-2021 | |
| Heraeus Medical, LLC. | $86.52 | 2025 | |
| Orthofix Medical, INC. | $33.70 | 2021 | |
| Sanofi-Aventis U.S. LLC | $27.97 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $26.89 | 2022 | |
| Stryker Corporation | $25.00 | 2023 | Triathlon |
| Molnlycke Health Care US, LLC | $14.52 | 2024 | Mepilex Border Sacrum, Mepilex Border Post-Op, Mepilex Ag |
| Vericel Corporation | $12.16 | 2019 | |
| Horizon Therapeutics Plc | $11.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jean-Benoit Houle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.